Robert E. Levitz
Impact in
- Microbiology top 10%
- Bacterial Infections and Vaccines
- Molecular Medicine top 10%
Papers in
- Epidemiology 13
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Infective Endocarditis Diagnosis and Management 4
- Pneumonia and Respiratory Infections 4
-
- Antibiotic Resistance in Bacteria 3
- Co-authors
- Brian W. Cooper (5 shared papers)Richard Quintiliani (6 shared papers)C H Nightingale (2 shared papers)Michael N. Dudley (2 shared papers)Richard C. Tilton (2 shared papers)Lee R. Brettman (2 shared papers)Christopher J. Grace (1 shared paper)C. W. Ingram (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (4 papers)The Journal of Infectious Diseases (3 papers)Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)American Journal of Clinical Pathology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert E. Levitz
19 papers receiving 498 citations
Peers
Comparison fields: 5 of 80
- Microbiology 72
- Molecular Medicine 57
- Epidemiology 292
- Hepatology 65
- Infectious Diseases 154
Countries citing papers authored by Robert E. Levitz
This map shows the geographic impact of Robert E. Levitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Levitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Levitz more than expected).
Fields of papers citing papers by Robert E. Levitz
This network shows the impact of papers produced by Robert E. Levitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Levitz. The network helps show where Robert E. Levitz may publish in the future.
Co-authors
The 16 scholars most cited alongside Robert E. Levitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 110 | |
| 2 | 1998 | 82 | |
| 3 | 1984 | 64 | |
| 4 | 1992 | 46 | |
| 5 | 1988 | 38 | |
| 6 | 1990 | 33 | |
| 7 | 1992 | 28 | |
| 8 | 1987 | 28 | |
| 9 | 1995 | 24 | |
| 10 | 1999 | 24 | |
| 11 | 1995 | 20 | |
| 12 | 1988 | 14 | |
| 13 | 1984 | 13 | |
| 14 | 1992 | 9 | |
| 15 | Infection with the human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae. | 1988 | 8 |
| 16 | 1987 | 6 | |
| 17 | 1988 | 6 | |
| 18 | 1987 | 3 | |
| 19 | 1991 | 2 |
About Robert E. Levitz
Robert E. Levitz is a scholar working on Epidemiology, Molecular Medicine, Infectious Diseases, Pharmacology and Microbiology, having authored 19 papers that have together received 558 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Infective Endocarditis Diagnosis and Management (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Pneumonia and Respiratory Infections (4 papers), Antibiotic Resistance in Bacteria (3 papers), Hepatitis C virus research (2 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Microbiology (72 citations), Molecular Medicine (57 citations), Epidemiology (292 citations), Hepatology (65 citations) and Infectious Diseases (154 citations). Robert E. Levitz has collaborated with scholars based in United States. Frequent co-authors include Brian W. Cooper, Richard Quintiliani, C H Nightingale, Michael N. Dudley, Richard C. Tilton, Lee R. Brettman, Christopher J. Grace, C H Nightingale, C. W. Ingram and Allan J. Morrison. Their work appears in journals such as Infection Control and Hospital Epidemiology, The Journal of Infectious Diseases, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.